Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Icet
    Junior Member
    • Nov 2014
    • 3

    #1

    Varying n of PCR cycles and biases in quantitative analysis

    Dear all,
    im performing a protocol in which i circularize the cDNA and then do the amplification PCR of the libraries.
    I process many samples, which i would prefer to treat identically as much as possible not to introduce any bias.
    With 12 PCR cycles some samples look great, some rather overamplified.
    (little note: I am aware that the overamplification can create artifacts and eventually clonal reads. But after performing the PCR i precipitate it and size select on a gel, so i dont have in my libraries any slower migrating byproduct).

    With many samples performing differently, it seems that keeping the PCR conditions similar for all of them is not really an option. Lowering the cycles would make me loose the samples where i seem to have lower cDNA input.

    My fear is however that varying the number of cycles for each sample will affect the quantitative interpretation of the data after sequencing (e.g. due to preferential amplification of specific products).
    I am afraid to introduce an unexpected bias, which would be deleterious if i want to do quantitative comparisons.

    What are your thoughts on that?

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Yesterday, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
29 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...